I'm an investor with GENE on the nasdaq. I became interested...

I'm an investor with GENE on the nasdaq. I became interested after the BTCS merger fell thru, and I caught wind of the board spill. I was interested in exposure with blockchain global, seemed to be huge potential. I originally thought BCG was just using Gene to gain entry to the nasdaq. But now it seems maybe thats not the case, and thats ok too, I like the ideas they have for the company.
It seems to me they would have had a good plan, assuming all the trouble they went to. But I admit, I am starting to get a little worried. I am down 22 percent after today, on about 7k USD. I could have taken a nice profit earlier but held on for the longer term. In some cases I would just average down, but here I am a little nervous to commit further.
My question is , was the strategic alliance with shivom considered to be blockchain opportunity #1 with bcg.
I took it to be a little something extra, a bonus to say. But here lately with no more news I am wondering is that it???
Maybe they got caught up in the bitcoin euphoria and thought they could turn anything to gold.

I hope blockchain opportunity #1 with bcg is still on the way soon, and I really hope its pretty good. because I dont think shivom is going to turn this one around. Any insight from Austrailia would be appreciated. I still have hope.